Palladia: Product Information (Page 5 of 5)

PRINCIPAL DISPLAY PANEL — 10 mg Tablet Bottle Label

Palladia ®
(toceranib phosphate)

10 mg per tablet

Antineoplastic for Oral Use in Dogs Only
Caution: Federal (USA) law restricts this drug to
use by or on the order of a licensed veterinarian.

10 mg toceranib per tabletNET CONTENTS: 30 Tablets

Approved by FDA under NADA # 141-295

zoetis

Palladia 10mg
(click image for full-size original)

Palladia 10mg

PRINCIPAL DISPLAY PANEL — 15 mg Tablet Bottle Label

Palladia ®
(toceranib phosphate)

15 mg per tablet

Antineoplastic for Oral Use in Dogs Only
Caution: Federal (USA) law restricts this drug to
use by or on the order of a licensed veterinarian.

15 mg toceranib per tabletNET CONTENTS: 30 Tablets

Approved by FDA under NADA # 141-295

zoetis

Palladia 15mg
(click image for full-size original)

Palladia 15mg

PRINCIPAL DISPLAY PANEL — 50 mg Tablet Bottle Label

Palladia ®
(toceranib phosphate)

50 mg per tablet

Antineoplastic for Oral Use in Dogs Only
Caution: Federal (USA) law restricts this drug to
use by or on the order of a licensed veterinarian.

50 mg toceranib per tabletNET CONTENTS: 30 Tablets

Approved by FDA under NADA # 141-295

zoetis

Palladia 50mg
(click image for full-size original)

Palladia 50mg

PALLADIA toceranib phosphate tablet
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:54771-1690
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TOCERANIB PHOSPHATE (TOCERANIB) TOCERANIB 10 mg
Product Characteristics
Color blue Score no score
Shape ROUND Size 7mm
Flavor Imprint Code TKI;10;Pfizer
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:54771-1690-1 30 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA141295 05/22/2009
PALLADIA toceranib phosphate tablet
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:54771-1691
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TOCERANIB PHOSPHATE (TOCERANIB) TOCERANIB 15 mg
Product Characteristics
Color orange Score no score
Shape ROUND Size 8mm
Flavor Imprint Code TKI;15;Pfizer
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:54771-1691-1 30 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA141295 05/22/2009
PALLADIA toceranib phosphate tablet
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:54771-1692
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TOCERANIB PHOSPHATE (TOCERANIB) TOCERANIB 50 mg
Product Characteristics
Color red Score no score
Shape ROUND Size 12mm
Flavor Imprint Code TKI;50;Pfizer
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:54771-1692-1 30 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA141295 05/22/2009
Labeler — Zoetis Inc. (828851555)

Revised: 03/2021 Zoetis Inc.

VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Our database mirrors the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VetLabel.com provides the full animal health subset of the FDA's repository. Veterinary information provided here is not intended as a substitute for direct consultation with a qualified veterinary professional.

Terms of Use | Copyright © 2021. All Rights Reserved.